Development of Objective Structured Assessment of Technical Skills in Facial Cosmetic Procedures: Botulinum Toxin Neuromodulator and Soft Tissue Filler Injection

Author(s):  
Kathleen C. Suozzi ◽  
Nour Kibbi ◽  
Kachiu C. Lee ◽  
Brandon Worley ◽  
Karina C. Furlan ◽  
...  
Author(s):  
Won Lee ◽  
Hyoung-Jin Moon ◽  
Ji-Soo Kim ◽  
Eun-Jung Yang

Abstract Background Glabellar wrinkle corrections are usually performed by injecting botulinum toxin and hyaluronic acid fillers. The glabella is one of the most dangerous locations for filler injection because of possible visual complications. Objectives The aim of this study was to use Doppler ultrasound to determine the anatomic relation between glabellar wrinkles and the supratrochlear artery pathway, perform safe hyaluronic acid filler injection to correct glabellar wrinkles, and determine the efficacy of the procedure. Methods From January 2019 to July 2019, 42 patients (74 glabellar wrinkle lines; 32 bilateral and 10 unilateral wrinkles) were evaluated. Glabellar wrinkle lines were corrected with hyaluronic acid filler. Doppler ultrasound was used to avoid the supratrochlear artery. Results Among the 74 wrinkle lines, the supratrochlear arteries were located either at the glabellar wrinkle lines (30/74, 41%) or lateral to the glabellar wrinkle lines (44/74, 59%). In the latter 44 wrinkles, fillers were injected into the subdermal layer of the glabellar wrinkle lines. In the 30 wrinkles where supratrochlear artery was located at the glabellar wrinkle lines, the artery was located at the deep subcutaneous layer in 24 and at the subdermal layer in 6; thus, filler injection was not performed. Conclusions The supratrochlear artery may be located either at or lateral to the glabellar wrinkle lines. When performing glabellar wrinkle correction, Doppler ultrasound can be used to confirm the location of the supratrochlear artery before filler injection, which helps in avoiding vascular complications. Level of Evidence: 4


2018 ◽  
Vol 44 (1) ◽  
pp. 84-91 ◽  
Author(s):  
Wolfgang G. Philipp-Dormston ◽  
Lara Bieler ◽  
Mathias Hessenberger ◽  
Thilo L. Schenck ◽  
Konstantin Frank ◽  
...  

2019 ◽  
Vol 18 (5) ◽  
pp. 1254-1260 ◽  
Author(s):  
Won Lee ◽  
Ji‐Soo Kim ◽  
Wook Oh ◽  
Ik‐Soo Koh ◽  
Eun‐Jung Yang

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Fei Liu ◽  
Yue Ma ◽  
Meiting Tang ◽  
Xueying Zeng ◽  
Don O. Kikkawa ◽  
...  

2021 ◽  
Vol 48 (1) ◽  
pp. 10-14
Author(s):  
Byeong Soo Kwon ◽  
Jin Woo Kim

Soft tissue filler injections are widely used due to their immediate effects, predictable results, and high stability. However, as the use of soft tissue filler injections has increased, various complications have been reported. We report a life-threatening complication in a patient who developed sepsis and necrotizing fasciitis. A 45-year-old woman presented with right leg pain and discharge from the labia majora. The patient had received a soft tissue filler injection of unknown composition 1 year earlier and had recently undergone incision and drainage for an inflammatory cystic nodule. Antibiotic treatment was administered for cellulitis, but the infection progressed to necrotizing fasciitis and sepsis. Fasciotomy and intensive care unit treatment improved the systemic infection, but the soft tissue filler injection site did not respond to treatment for 1 month. Thus, the injection site was covered with a pedicled vertical rectus abdominis musculocutaneous flap after wide excision. The area of skin necrosis on the leg was covered with split-thickness skin grafts. Infections occurring after soft tissue filler injections are related to biofilms, and treatment is sometimes difficult. Therefore, although soft tissue filler injections have a favorable safety profile, it is important to be aware of the risk of life-threatening complications.


Sign in / Sign up

Export Citation Format

Share Document